Trial Profile
A retrospective trial to evaluate the efficacy and safety of the SYNERGY Everolimus-eluting stent in patients undergoing percutaneous coronary interventions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions; Therapeutic Use
- 27 Feb 2016 New trial record